Home› The Breastcancer.org Community Forum› Living with metastatic disease› Stage IV/Metastatic Breast Cancer, Open to All To Contribute
We've made it easier for you to connect! Fill out your NEW profile.

FDA Approves Orserdu for ER+ MBC (oral SERD)

moderators
moderators Posts: 9,078
February 2023 edited February 2023 in Stage IV/Metastatic Breast Cancer, Open to All To Contribute

FDA Approves Orserdu for Metastatic, Estrogen Receptor-Positive Breast Cancer
Jan 27, 2023

The FDA has approved Orserdu, a new oral medicine to treat metastatic, estrogen receptor-positive, HER2-negative breast cancer with an ESR1 mutation. Read more....

0

Categories

  • All Categories
  • 1.3K Concerned about my risk
  • 1.5K Connect with others like me
  • 2.1K In treatment
  • 563 Managing life with cancer
  • 153 Finished treatment
  • 823 Living with metastatic disease
  • 51 Caring for someone
  • 268 Tributes
  • 34 Discussion forum resources
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.